145 related articles for article (PubMed ID: 20399629)
1. Continuous hyperfractionated accelerated radiotherapy (CHART) and non-conventionally fractionated radiotherapy in the treatment of non-small cell lung cancer: a review and consideration of future directions.
Hatton MQ; Martin JE
Clin Oncol (R Coll Radiol); 2010 Jun; 22(5):356-64. PubMed ID: 20399629
[TBL] [Abstract][Full Text] [Related]
2. Localized small-cell lung cancer: which type of thoracic radiotherapy and which time schedule.
Stuschke M; Pöttgen C
Lung Cancer; 2004 Aug; 45 Suppl 2():S133-7. PubMed ID: 15552793
[TBL] [Abstract][Full Text] [Related]
3. Accelerated radical radiotherapy for non-small cell lung cancer using two common regimens: a single-centre retrospective study of outcome.
Pemberton LS; Din OS; Fisher PM; Hatton MQ
Clin Oncol (R Coll Radiol); 2009 Apr; 21(3):161-7. PubMed ID: 19111452
[TBL] [Abstract][Full Text] [Related]
4. [The recent progress in chemoradiotherapy of lung cancer].
Ogawara M; Kawahara M; Furuse K
Gan To Kagaku Ryoho; 1997 Nov; 24(14):2058-64. PubMed ID: 9388514
[TBL] [Abstract][Full Text] [Related]
5. Different fraction schedules and combinations with chemotherapy in radiation treatment of non-small cell lung cancer.
Brattström D; Bergqvist M; Hesselius P; Wagenius G; Brodin O
Anticancer Res; 2000; 20(3B):2087-90. PubMed ID: 10928157
[TBL] [Abstract][Full Text] [Related]
6. Routine use of continuous, hyperfractionated, accelerated radiotherapy for non-small-cell lung cancer: a five-center experience.
Din OS; Lester J; Cameron A; Ironside J; Gee A; Falk S; Morgan SA; Worvill J; Hatton MQ
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):716-22. PubMed ID: 18355975
[TBL] [Abstract][Full Text] [Related]
7. The possible advantage of hyperfractionated thoracic radiotherapy in the treatment of locally advanced nonsmall cell lung carcinoma: results of a North Central Cancer Treatment Group Phase III Study.
Bonner JA; McGinnis WL; Stella PJ; Marschke RF; Sloan JA; Shaw EG; Mailliard JA; Creagan ET; Ahuja RK; Johnson PA
Cancer; 1998 Mar; 82(6):1037-48. PubMed ID: 9506347
[TBL] [Abstract][Full Text] [Related]
8. [Current progress in the radiotherapeutic treatment of non-small-cell lung cancer].
Van Houtte P
Rev Med Brux; 1995; 16(1):14-9. PubMed ID: 7701161
[TBL] [Abstract][Full Text] [Related]
9. [Phase III studies of combined chemotherapy and radiation in locally advanced non-small-cell lung cancer and limited small-cell lung cancer].
Kawahara M
Gan To Kagaku Ryoho; 1995 Feb; 22(3):335-40. PubMed ID: 7880104
[TBL] [Abstract][Full Text] [Related]
10. A phase II study of cisplatin and 5-fluorouracil with concurrent hyperfractionated thoracic radiation for locally advanced non-small-cell lung cancer: a preliminary report from the Okayama Lung Cancer Study Group.
Segawa Y; Ueoka H; Kiura K; Kamei H; Tabata M; Sakae K; Hiraki Y; Kawahara S; Eguchi K; Hiraki S; Harada M
Br J Cancer; 2000 Jan; 82(1):104-11. PubMed ID: 10638975
[TBL] [Abstract][Full Text] [Related]
11. Trials of radical radiotherapy versus chemotherapy plus radical radiotherapy in non-small cell lung cancer.
Cullen MH
Semin Oncol; 1994 Jun; 21(3 Suppl 4):34-41. PubMed ID: 8209275
[TBL] [Abstract][Full Text] [Related]
12. [The state of the art: radiation therapy for non-small cell lung cancer].
Chatani M
Gan To Kagaku Ryoho; 1997 Oct; 24 Suppl 3():373-8. PubMed ID: 9369910
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. Non-small Cell Lung Cancer Collaborative Group.
BMJ; 1995 Oct; 311(7010):899-909. PubMed ID: 7580546
[TBL] [Abstract][Full Text] [Related]
14. [Combined modality treatment of chemotherapy and radiotherapy for unresectable non-small cell lung cancer].
Kubota K
Gan To Kagaku Ryoho; 1997 Oct; 24 Suppl 3():384-9. PubMed ID: 9369912
[TBL] [Abstract][Full Text] [Related]
15. Phase III study of the Eastern Cooperative Oncology Group (ECOG 2597): induction chemotherapy followed by either standard thoracic radiotherapy or hyperfractionated accelerated radiotherapy for patients with unresectable stage IIIA and B non-small-cell lung cancer.
Belani CP; Wang W; Johnson DH; Wagner H; Schiller J; Veeder M; Mehta M;
J Clin Oncol; 2005 Jun; 23(16):3760-7. PubMed ID: 15837967
[TBL] [Abstract][Full Text] [Related]
16. From conventionally fractionated radiation therapy to hyperfractionated radiation therapy alone and with concurrent chemotherapy in patients with early-stage nonsmall cell lung cancer.
Jeremić B; Milicić B
Cancer; 2008 Feb; 112(4):876-84. PubMed ID: 18172901
[TBL] [Abstract][Full Text] [Related]
17. ["State of the art" of chemotherapy for lung cancer].
Fukuoka M
Gan To Kagaku Ryoho; 1993 Dec; 20(16):2429-36. PubMed ID: 8279838
[TBL] [Abstract][Full Text] [Related]
18. Induction paclitaxel and carboplatin followed by concurrent chemoradiotherapy in patients with unresectable, locally advanced non-small cell lung carcinoma: report of Fox Chase Cancer Center study 94-001.
Langer CJ; Movsas B; Hudes R; Schol J; Keenan E; Kilpatrick D; Yeung C; Curran W
Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-89-S12-95. PubMed ID: 9331129
[TBL] [Abstract][Full Text] [Related]
19. Escalated hyperfractionated accelerated radiation therapy for locally advanced non-small cell lung cancer: a clinical phase II trial.
Chen GY; Jiang GL; Qian H; Wang LJ; Yang HJ; Fu XL; Wu KL; Zang Z; Zhao S
Radiother Oncol; 2004 May; 71(2):157-62. PubMed ID: 15110448
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of lung cancer--state of the art in 2000].
Nakanishi Y; Inoue K; Hara N
Gan To Kagaku Ryoho; 2000 Jul; 27(8):1247-52. PubMed ID: 10945023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]